Validation of cytogenetic-based risk stratification in primary myelofibrosis.
Rumi
Elisa
E
Passamonti
Francesco
F
Bernasconi
Paolo
P
Arcaini
Luca
L
Pietra
Daniela
D
Elena
Chiara
C
Boveri
Emanuela
E
Pascutto
Cristiana
C
Cazzola
Mario
M
Lazzarino
Mario
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002869:Chromosome Aberrations; D002872:Chromosome Deletion; D020732:Cytogenetic Analysis; D005260:Female; D006801:Humans; D053614:Janus Kinase 2 / Q000502:physiology; D053208:Kaplan-Meier Estimate; D007621:Karyotyping; D008297:Male; D008875:Middle Aged; D055728:Primary Myelofibrosis / Q000453:epidemiology* / Q000235:genetics / Q000473:pathology; D011379:Prognosis; D018570:Risk Assessment; D055815:Young Adult
C507924:JAK2 protein, human; D053614:Janus Kinase 2